A detailed history of Lmr Partners LLP transactions in Surmodics Inc stock. As of the latest transaction made, Lmr Partners LLP holds 17,350 shares of SRDX stock, worth $561,619. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,350
Previous 83,083 79.12%
Holding current value
$561,619
Previous $2.54 Million 79.69%
% of portfolio
0.0%
Previous 0.03%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

SELL
$26.76 - $31.1 $1.76 Million - $2.04 Million
-65,733 Reduced 79.12%
17,350 $515,000
Q1 2025

May 15, 2025

BUY
$26.71 - $39.71 $2.22 Million - $3.3 Million
83,083 New
83,083 $2.54 Million

Others Institutions Holding SRDX

About SURMODICS INC


  • Ticker SRDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,005,000
  • Market Cap $453M
  • Description
  • Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...
More about SRDX
Track This Portfolio

Track Lmr Partners LLP Portfolio

Follow Lmr Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Lmr Partners LLP with notifications on news.